1.
Curr Med Chem
; 19(21): 3457-74, 2012.
Artículo
en Inglés
| MEDLINE
| ID: mdl-22709008
RESUMEN
The high distribution of CB(2) receptors in immune cells suggests their important role in the control of inflammation. Growing evidence offers this receptor as an attractive therapeutic target: CB(2) selective agonists are able to modulate inflammation without triggering psychotropic effects. This review will summarize the literature on the implication of CB(2) in inflammation and CB(2) selective agonists with anti-inflammatory activity.